Your browser doesn't support javascript.
loading
Danthron attenuates experimental atherosclerosis by targeting foam cell formation.
Shi, Xiujin; Zhang, Yi; Lin, Baidi; Zhou, Yang; Suo, Wei; Wei, Juanjuan; Zhang, Lin; Lin, Jie; Xiao, Fucheng; Zhao, Limin; Lin, Yang.
  • Shi X; Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Zhang Y; Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Lin B; Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Zhou Y; Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Suo W; Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Wei J; Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Zhang L; Department of Pharmacy, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Lin J; Department of Endocrinology and Metabolism, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Xiao F; Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, 100029, China.
  • Zhao L; Department of Cardiovascular Surgery, Beijing Anzhen Hospital, Capital Medical University, Beijing, 100029, China.
  • Lin Y; Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing, 100029, China.
Exp Physiol ; 106(3): 653-662, 2021 03.
Article en En | MEDLINE | ID: mdl-33450102

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Células Espumosas Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Aterosclerosis / Células Espumosas Límite: Animals Idioma: En Año: 2021 Tipo del documento: Article